Drug comparisons
Linagliptin vs Acarbose
Compare Linagliptin (Tradjenta) and Acarbose (Precose) for type 2 diabetes. Differences in mechanism, side effects, efficacy, and suitability.
No comparison dimensions are available for this page.
Clinical context
This comparison arises when choosing an oral add-on agent for type 2 diabetes after metformin, weighing DPP-4 inhibition against alpha-glucosidase inhibition.
Bottom line
Linagliptin is generally better tolerated and more convenient, but Acarbose may suit patients focused on post-meal glucose control.
All medication comparisons